Molecular Targets in Oncology: Implications of the Multidrug Resistance Gene

Abstract excerpt

The curative potential of chemotherapy for a number of tumor types has been obscured by the fact that many patients initially have striking remissions but later relapse and die. At the time of relapse many patients manifest resistance to a wide array of structurally unrelated antineoplastic agents, hence the term multidrug resistance (MDR). Other tumor types, such as those arising in the colon, kidneys, liver,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer therapeutics and mechanisms
• Share to Drug Transport and Resistance Mechanisms
• Share to Pancreatic and Hepatic Oncology Research